DocGo Inc. Revenue
DocGo Inc. (DCGO) reported Revenue of $73.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-17
- DocGo Inc. revenues for the quarter ending 2026-06-30 was $73.42M, a 8.70% decline year-over-year.
- DocGo Inc. revenues for the quarter ending 2026-03-31 was $75.55M, a 21.33% decline year-over-year.
- DocGo Inc. revenues for the quarter ending 2025-12-31 was $74.94M, a 37.98% decline year-over-year.
- DocGo Inc. revenues for the quarter ending 2025-09-30 was $70.81M, a 48.94% decline year-over-year.
- DocGo Inc. revenues for fiscal 2025 was $322.20M, a 47.74% decline from fiscal 2024.
- DocGo Inc. revenues for fiscal 2024 was $616.56M, a 1.24% decline from fiscal 2023.
- DocGo Inc. revenues for fiscal 2023 was $624.29M, a 41.72% increase from fiscal 2022.
- DocGo Inc. revenues for fiscal 2022 was $440.52M, a 38.21% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $73.42M 10-Q · filed 2026-08-17 | $148.98M 10-Q · filed 2026-08-17 | $223.91M derived: sum of 3 quarters · filed 2026-08-17 | $294.72M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $75.55M 10-Q · filed 2026-05-11 | $150.49M derived: sum of 2 quarters · filed 2026-05-11 | $221.30M derived: sum of 3 quarters · filed 2026-05-11 | $301.71M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $74.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $145.75M derived: sum of 2 quarters · filed 2026-03-16 | $226.16M derived: sum of 3 quarters · filed 2026-08-17 | $322.20M 10-K · filed 2026-03-16 |
| 2025-09-30 | $70.81M 10-Q · filed 2025-11-10 | $151.23M derived: sum of 2 quarters · filed 2026-08-17 | $247.26M 10-Q · filed 2025-11-10 | $368.09M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $80.42M 10-Q · filed 2026-08-17 | $176.45M 10-Q · filed 2026-08-17 | $297.28M derived: sum of 3 quarters · filed 2026-08-17 | $435.97M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $96.03M 10-Q · filed 2026-05-11 | $216.87M derived: sum of 2 quarters · filed 2026-05-11 | $355.55M derived: sum of 3 quarters · filed 2026-05-11 | $520.50M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $120.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $259.52M derived: sum of 2 quarters · filed 2026-03-16 | $424.47M derived: sum of 3 quarters · filed 2026-03-16 | $616.56M 10-K · filed 2026-03-16 |
| 2024-09-30 | $138.68M 10-Q · filed 2025-11-10 | $303.63M derived: sum of 2 quarters · filed 2025-11-10 | $495.72M 10-Q · filed 2025-11-10 | $694.97M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $164.95M 10-Q · filed 2025-08-07 | $357.04M 10-Q · filed 2025-08-07 | $556.28M derived: sum of 3 quarters · filed 2026-03-16 | $742.84M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $192.09M 10-Q · filed 2025-05-08 | $391.33M derived: sum of 2 quarters · filed 2026-03-16 | $577.89M derived: sum of 3 quarters · filed 2026-03-16 | $703.37M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $199.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $385.80M derived: sum of 2 quarters · filed 2026-03-16 | $511.29M derived: sum of 3 quarters · filed 2026-03-16 | $624.29M 10-K · filed 2026-03-16 |
| 2023-09-30 | $186.55M 10-Q · filed 2024-11-07 | $312.04M derived: sum of 2 quarters · filed 2024-11-07 | $425.04M 10-Q · filed 2024-11-07 | $533.83M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $125.49M 10-Q · filed 2024-08-07 | $238.49M 10-Q · filed 2024-08-07 | $347.27M derived: sum of 3 quarters · filed 2025-02-27 | $451.59M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $113.00M 10-Q · filed 2024-05-08 | $221.79M derived: sum of 2 quarters · filed 2025-02-27 | $326.11M derived: sum of 3 quarters · filed 2025-02-27 | $435.63M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $108.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $213.10M derived: sum of 2 quarters · filed 2025-02-27 | $322.62M derived: sum of 3 quarters · filed 2025-02-27 | $440.52M 10-K · filed 2025-02-27 |
| 2022-09-30 | $104.32M 10-Q · filed 2023-11-06 | $213.84M derived: sum of 2 quarters · filed 2023-11-06 | $331.73M 10-Q · filed 2023-11-06 | $453.05M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $109.52M 10-Q · filed 2023-08-08 | $227.41M 10-Q · filed 2023-08-08 | $348.74M derived: sum of 3 quarters · filed 2024-02-28 | $434.57M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $117.89M 10-Q · filed 2023-05-09 | $239.22M derived: sum of 2 quarters · filed 2024-02-28 | $325.05M derived: sum of 3 quarters · filed 2024-02-28 | $387.24M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $121.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $207.16M derived: sum of 2 quarters · filed 2024-02-28 | $269.35M derived: sum of 3 quarters · filed 2024-02-28 | $318.72M 10-K · filed 2024-02-28 |
| 2021-09-30 | $85.84M 10-Q · filed 2022-11-08 | $148.02M derived: sum of 2 quarters · filed 2022-11-08 | $197.39M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $62.19M 10-Q · filed 2022-08-09 | $111.56M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $49.69M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $94.09M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |